Mindray BC-5390 CRP Automated Hematology Analyzer – Medical Grade Professional (Healthcare)

Professional general medical supplies for medical applications. Clinical grade quality, reliable performance. Healthcare facilities.
Combining the advanced technology of hematology analysis and latex immunoturbidimetry, BC-5390 CRP/BC-5310 CRP requires only 35_l blood from a single blood tube, to simultaneously provide results of WBC 5-part differentiation and FR-CRP at a throughput speed of 60 samples/hour.
C-reactive protein (CRP) is an important diagnostic parameter to detect inflammation, monitor progress of inflammatory process or effectiveness of therapeutic treatment. The availability of CRP and WBC parameter data simultaneously can help with prompt differentiation of bacterial infections from viral infections.
Features
Dual CRP Analysis Channels for High Throughput
Dual CRP analysis channels working together save waiting time of consecutive tests between hematology and CRP test, enabling a CBC+DIFF+CRP throughput of up to 60 samples per hour, which is the fastest in the industry for the same mode of measurement.
Latex Immunoturbidimetric Technology
Advanced and proven Latex Immunoturbidimetric technology plus two reagents can well guarantee the analyzing accuracy in fast dual-channel CBC+DIFF+CRP test.
Powerful reagent
New powerful reagent improves the 5-part WBC differentiation ability (especially in samples with high number of Eosinophils) and ability to process aged samples (maintained at ambient temperatures for up to 24 hours)
NRBC parameters and flag
BC-5390 CRP/BC-5310 CRP can flag ?NRBC? research parameters called NRBC# and NRBC%, which represent respectively the number and ratio of the nucleated red blood cells, facilitating doctors with important diagnostic inferences.
NLR parameter in each CBC+DIFF

Neutrophil-to-lymphocyte ratio (NLR) is calculated by dividing neutrophil count by lymphocyte count, usually from peripheral blood sample.

In laboratory medicine, NLR is used as a marker of subclinical inflammation.

According to clinical studies, NLR can be used as a prognostic factor of severe illness in COVID-19 patients.